Evidence map›Paper›PMID 37443575›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Glycans as Potential Diagnostic Markers of Traumatic Brain Injury in Children.

Mårten Kvist, Lasse Välimaa, Adrian Harel, Sari Malmi, Aleksi Tuomisto

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mårten KvistMedicortex Finland Plc, 20520 Turku, Finland.ORCID 0000-0002-5229-3816
Lasse VälimaaMedicortex Finland Plc, 20520 Turku, Finland.ORCID 0000-0003-2027-0406
Adrian HarelMedicortex Finland Plc, 20520 Turku, Finland.
Sari MalmiDepartment of Pediatric Surgery, Satasairaala Hospital, 28500 Pori, Finland.
Aleksi TuomistoDepartment of Pediatric Surgery, Satasairaala Hospital, 28500 Pori, Finland.
Satakunta Central Hospital · FI

Funding

Business Finland 44307/31/2020
6 · The paper itself

Abstract

Diagnosing mild traumatic brain injury (TBI) in the acute setting is challenging due to the nonspecific and often transient or delayed symptoms. Further, the criteria for acute head imaging are frequently not fulfilled, which may lead to a missed diagnosis. A rapid test to diagnose TBI using body fluids would be highly useful. Urine and saliva samples were collected from 28 pediatric patients (mean [SD] age, eight years two months [four years three months]) with acute, clinically diagnosed mild TBI and 30 healthy volunteers at Satasairaala Hospital, Pori, Finland, over 11 months. The mean (SD) time from trauma to first sampling was 3 h 56 min (1 h 14 min). Samples were analyzed to determine the number of lectin-binding glycan molecules, indicating nerve tissue damage. The relative levels of several lectin-bound glycans were measured by fluorescence. Compared with healthy controls, the TBI group showed significant increases (

Indexed as

biomarkerchildrenclinical trialconcussiondiagnostic testglycanlectinTBItraumatic brain injury

Identifiers

PMID37443575
PMCPMC10340482
OpenAlexW4382449761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.